GT Diagnostics and TauRx Therapeutics Ltd. will be presenting at the Alzheimer Europe Conference on Nov 29th – Dec 1st 2021.
Our focus during the special symposium will be to discuss late-stage clinical trial conduct during COVID-19: challenges, lessons, and the future for Alzheimer’s disease management.
Event begins on 1st Dec 2021 @ 1:00pm (CET):
1. Introduction: the shifting patient pathway in AD
(Dr Serge Gauthier)
2. Conducting a phase 3 trial in a global pandemic – how we managed our trial
(Dr Sonya Miller)
3. New diagnostic tools for early detection and monitoring of dementia
(Dr Linda Sommerlade)
4. Data collection during COVID-19 and dementia insights
(Prof Bjoern Schelter)
